These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9804773)

  • 21. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
    Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.
    Tagami T; Madison LD; Nagaya T; Jameson JL
    Mol Cell Biol; 1997 May; 17(5):2642-8. PubMed ID: 9111334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.
    Collingwood TN; Wagner R; Matthews CH; Clifton-Bligh RJ; Gurnell M; Rajanayagam O; Agostini M; Fletterick RJ; Beck-Peccoz P; Reinhardt W; Binder G; Ranke MB; Hermus A; Hesch RD; Lazarus J; Newrick P; Parfitt V; Raggatt P; de Zegher F; Chatterjee VK
    EMBO J; 1998 Aug; 17(16):4760-70. PubMed ID: 9707435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
    Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavaillès V; Kalkhoven E; Matthews C; Nystrom E; Stenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VK
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):248-53. PubMed ID: 8990194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding.
    Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y
    Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.
    Reutrakul S; Sadow PM; Pannain S; Pohlenz J; Carvalho GA; Macchia PE; Weiss RE; Refetoff S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3609-17. PubMed ID: 11061510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
    Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
    Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
    Lin KH; Wu YH; Chen SL
    Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression.
    Gloss B; Giannocco G; Swanson EA; Moriscot AS; Chiellini G; Scanlan T; Baxter JD; Dillmann WH
    Endocrinology; 2005 Nov; 146(11):4926-33. PubMed ID: 16081636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.
    Vella KR; Ramadoss P; Costa-E-Sousa RH; Astapova I; Ye FD; Holtz KA; Harris JC; Hollenberg AN
    Mol Cell Biol; 2014 May; 34(9):1564-75. PubMed ID: 24550004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
    Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
    Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
    Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
    Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone.
    Ramos HE; Weiss RE
    Thyroid; 2006 Mar; 16(3):211-6. PubMed ID: 16571082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.
    Astapova I; Lee LJ; Morales C; Tauber S; Bilban M; Hollenberg AN
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19544-9. PubMed ID: 19052228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?
    Hayashi Y; Weiss RE; Sarne DH; Yen PM; Sunthornthepvarakul T; Marcocci C; Chin WW; Refetoff S
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3246-56. PubMed ID: 7593433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TR surfaces and conformations required to bind nuclear receptor corepressor.
    Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
    Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.